CD36 and gastric cancer: Indeed, palmitate-induced metastasis of gastric cancer is dependent on CD36, and high CD36 expression levels in gastric cancer patients correlate with poor clinical outcome; therefore, there is a possibility that blocking of the CD36–palmitate axis may serve as a potential gastric cancer treatment [83].